Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast cancer models.
Devarajan R, Izzi V, Peltoketo H, Rask G, Kauppila S, Väisänen MR, Ruotsalainen H, Martínez-Nieto G, Karppinen SM, Väisänen T, Kaur I, Koivunen J, Sasaki T, Winqvist R, Manninen A, Wärnberg F, Sund M, Pihlajaniemi T, Heljasvaara R.
Devarajan R, et al. Among authors: peltoketo h.
J Clin Invest. 2023 Sep 15;133(18):e159181. doi: 10.1172/JCI159181.
J Clin Invest. 2023.
PMID: 37498672
Free PMC article.